On April 29th, the U.S. FDA granted full approval for Seagen Inc.'s TIVDAK® (tisotumab vedotin) targeting tissue factor (TF) for the treatment of patients with recurrent or metastatic cervical cancer who have progressed on or after chemotherapy.

Enables users to replace multiple techniques with a single streamlined NGS process for faster results.

Olden Labs emerges from stealth to unveil a new approach to animal research. By harnessing artificial intelligence (AI), genetic engineering and robotics, Olden Labs is building the world’s first automated animal research lab.

First commercial source of on-demand GMP CD34+ hematopoietic stem cells for clinical manufacturing in the industry. OrganaBio leveraging years of in-house tissue sourcing and cell isolation experience to produce high-quality GMP-compliant cells.

The UK’s Medical Research Council is funding a 10-patient Phase I study to deliver rapid personalised treatment for lung cancer patients.

Highly sensitive and multiplexed assay for the detection, discrimination, and quantification of key mutations in ESR1 gene for breast cancer, developed for bio-Rad’s QX600™ droplet digital™ PCR system.

Arrayjet’s patented spot-on-spot microarray screening technology is available for customers to adopt in-house and via Arrayjet’s CRO/CMO services.

Erasmus University Medical Center uses ENPICOM’s IGX Platform and services to advance their research on identifying cancer nanobodies.

High accuracy and detection to identify tumor variants from degraded and low input samples as well as samples with limited DNA abundance. Library preparation kit adds to Twist’s portfolio of tools to enable liquid biopsy applications

Cancer Research UK and Stitch are pleased to announce the expansion of their partnership, focused on enhancing the patient experience within clinical trials.